EXQOR
Live / Registered — Registered — Section 8 accepted (as of 18 Dec 2024)
What this means for you
Registered since 02 Apr 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86797510
- Registration number
- 5715798
- Mark type
- Stylized text
- Filed
- 23 Oct 2015
- Published for opposition
- 17 May 2016
- Registered
- 02 Apr 2019
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating central nervous system (CNS) diseases and disorders
Owner
- ExQor Technologies, Inc., Boston, MA, US
- ExQor Technologies, Inc., Boston, MA, US
- ExQor Technologies, Inc., Boston, MA, US
Prosecution history
- 18 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 18 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 18 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Apr 2024 — TEAS SECTION 8 RECEIVED
- 02 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Feb 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Feb 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Feb 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Feb 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Oct 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Oct 2018 — NON-FINAL ACTION E-MAILED
- 04 Oct 2018 — SU - NON-FINAL ACTION - WRITTEN
- 04 Oct 2018 — STATEMENT OF USE PROCESSING COMPLETE